Investigating the immune effects of carbon ion radiation therapy for pancreatic cancer

Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer

NIH-funded research Albert Einstein College of Medicine · NIH-11005715

This study is looking at how a special type of radiation therapy called carbon ion radiation therapy might help boost the immune system to fight pancreatic cancer better than regular X-ray therapy, and it's being tested in mice to see if it could lead to new treatment options for patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine NIH-funded
Lab location1 site (Bronx, United States)
Project IDNIH-11005715 on NIH RePORTER

What this research studies

This research explores how carbon ion radiation therapy (CIRT) can enhance the immune response against pancreatic cancer. By comparing CIRT to traditional X-ray radiation therapy, the study aims to understand how CIRT's unique properties can lead to better tumor control and potentially improve patient outcomes. The research involves testing these therapies in a mouse model to evaluate their effectiveness in stimulating the immune system to fight cancer. If successful, this approach could lead to new treatment options for patients with pancreatic cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with pancreatic cancer who are seeking innovative treatment options.

Not a fit: Patients with non-cancerous conditions or those who are not diagnosed with pancreatic cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a novel treatment option that enhances the immune response against pancreatic cancer, potentially improving survival rates.

How similar studies have performed: While carbon ion therapy is a relatively novel approach, previous studies with proton therapy have shown promising results in enhancing tumor control and immune response.

Where this research is happening

Bronx, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.